Author:
Đambić Vedran,Pojatić Đorđe,Stažić Anto,Kibel Aleksandar
Reference130 articles.
1. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nature Reviews. Disease Primers. 2018;4:18014. DOI: 10.1038/nrdp.2018.14
2. Arendse LB, Danser AHJ, Poglitsch M, Touyz RM, Burnett JC Jr, Llorens-Cortes C, et al. Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacological Reviews. 2019;71(4):539-570. DOI: 10.1124/pr.118.017129
3. Mirabito Colafella KM, Bovée DM, Danser AHJ. The renin-angiotensin-aldosterone system and its therapeutic targets. Experimental Eye Research. 2019;186(May):107680
4. Gant CM, Laverman GD, Vogt L, Slagman MCJ, Heerspink HJL, Waanders F, et al. Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels. BMC Nephrology. 2017;18(1):1-8
5. Liu Y, Li L, Qiu M, Tan L, Zhang M, Li J, et al. Renal and cerebral ras interaction contributes to diabetic kidney disease. American Journal of Translational Research. 2019;11(5):2925-2939
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献